These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12154051)

  • 21. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z; Koeneman KS; Corey DR
    Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
    Xu Y; Wang X; Chen SM; Chen C; Wang Y; Xiao BK; Tao ZZ
    Am J Otolaryngol; 2016; 37(6):552-558. PubMed ID: 27726944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyzing Interaction of Rhodacyanine Inhibitor 'MKT-077' with
    Nainani KC; Upadhyay V; Singh B; Sandhu KK; Kaur S; Hora R; Mishra PC
    Drug Metab Bioanal Lett; 2024; 17(1):34-41. PubMed ID: 38231055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase and its potential for therapeutic intervention.
    Phatak P; Burger AM
    Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
    Britten CD; Rowinsky EK; Baker SD; Weiss GR; Smith L; Stephenson J; Rothenberg M; Smetzer L; Cramer J; Collins W; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 2000 Jan; 6(1):42-9. PubMed ID: 10656430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
    Jafri MA; Ansari SA; Alqahtani MH; Shay JW
    Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analogs of the Heat Shock Protein 70 Inhibitor MKT-077 Suppress Medullary Thyroid Carcinoma Cells.
    Hong SK; Starenki D; Johnson OT; Gestwicki JE; Park JI
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the telosome: therapeutic implications.
    Folini M; Gandellini P; Zaffaroni N
    Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer treatment by telomerase inhibitors: predictions by a kinetic model.
    Sidorov IA; Hirsch KS; Harley CB; Dimitrov DS
    Math Biosci; 2003 Feb; 181(2):209-21. PubMed ID: 12445762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model.
    Walker C; Böttger S; Low B
    Am J Pathol; 2006 May; 168(5):1526-30. PubMed ID: 16651619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
    Kang MK; Guo W; Park NH
    Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
    Vaziri H; Benchimol S
    Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
    Zhang RG; Zhang RP; Wang XW; Xie H
    Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
    Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
    Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.
    Miyata Y; Li X; Lee HF; Jinwal UK; Srinivasan SR; Seguin SP; Young ZT; Brodsky JL; Dickey CA; Sun D; Gestwicki JE
    ACS Chem Neurosci; 2013 Jun; 4(6):930-9. PubMed ID: 23472668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.